JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $20,195,000 | +10.3% | 441,800 | +8.2% | 0.05% | 0.0% |
| Q3 2017 | $18,315,000 | +70.1% | 408,268 | -11.9% | 0.05% | +57.6% |
| Q2 2017 | $10,766,000 | +26.1% | 463,435 | +20.5% | 0.03% | +17.9% |
| Q1 2017 | $8,538,000 | +34.2% | 384,745 | +14.0% | 0.03% | +16.7% |
| Q4 2016 | $6,362,000 | -29.8% | 337,478 | +11.7% | 0.02% | -29.4% |
| Q3 2016 | $9,066,000 | +15.7% | 302,114 | +67.4% | 0.03% | +9.7% |
| Q2 2016 | $7,836,000 | – | 180,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|